Received Feb 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 5YB5G | IM / LA |
Reported Symptoms: 10047862:WEAKNESS; 10047865:WEAKNESS GENERALIZED; Narrative: Per provider note: 94 year old male with PMHx of HFrEF (<20%), HTN, SSS s/p PPM, PMR, BPH, Osteoarthritis and Osteoporosis who present for weakness. Patient first presented to ED on 12/6/24 after experiencing a ground level fall. While in the ED he received a dose of the TDAP (Boostrix) vaccine. He tripped on a step and fell hitting the left side of his head on the wall. Patient's only complaint was mild headache. He was at his baseline state of health before and after the fall. CT head was negative. CT C spine revealed age indeterminate C4 fracture. No tenderness over cervical spine. Neurosurgery weighed in on imaging finding and determined no intervention since most likely present before fall. Patient was discharged from the ED with strict return precautions. Of note, he received TDAP vaccine prior to discharge. Patient went home and later developed weakness. He states around 11pm he woke up, got disoriented and couldnt find walker. He laid on the ground and crawed around home until 6pm the next day. Couldnt stand or walk. He denies falling, hitting his head or LOC. Only complaint is generalized weakness. Neurologist was consulted who stated this weakness isnt consistent with spinal cord injury or Guillain-Barre. Neurologist was concerned that the vaccine could have flared up PMR. Other Relevant HX: Other: weakness